Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07379801

The Musculoskeletal System During Puberty in Dancers With Scoliosis, and the Effect of an Exercise Program

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
University of Haifa · Academic / Other
Sex
Female
Age
11 Years – 16 Years
Healthy volunteers
Accepted

Summary

assessment of the musculoskeletal system will be performed twice a year, for three years of young dancers

Detailed description

Objectives: To examine musculoskeletal system characteristics in female dancers with and without scoliosis throughout the pubertal period, and to evaluate the effect of a targeted preventive exercise program. Methods: Up to 140 female dancers aged 11-16 will be recruited for a two-phase study: Phase A: a two-year longitudinal study with four assessment time points. . At each time point, participants will complete a comprehensive assessment including: anthropometric measurements (height and weight), sexual maturation status (Tanner scale), scoliosis assessment (Adam's forward bend test, scoliometer measurements, Scoliosis Research Society-22 questionnaire), bone strength (quantitative ultrasound using a Speed of Sound \[SOS\] device), abdominal and back muscle morphology (ultrasound imaging), hip muscle strength (handheld dynamometry), hip range of motion (goniometry), dynamic balance (Y Balance Test), and flexibility (Beighton score). In addition, participants will complete a demographic questionnaire and an injury surveillance questionnaire. Phase B : an intervention study in which dancers with scoliosis will be randomly assigned to either a three-month targeted exercise program or a control group continuing regular training. Outcomes will be assessed post-intervention and at one-year follow-up.

Conditions

Interventions

TypeNameDescription
OTHERexerciseexercise for strengthening core muscles

Timeline

Start date
2026-01-30
Primary completion
2028-08-30
Completion
2028-08-30
First posted
2026-01-30
Last updated
2026-02-03

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT07379801. Inclusion in this directory is not an endorsement.